Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Integrated Core Strategies (US) LLC reported a 5.50% stake in Unicycive Therapeutics, Inc. (Schedule 13G)
Event Jan 16, 2026 · Filed Jan 23, 2026
Integrated Core Strategies (US) LLC reported a 5.50% stake in Unicycive Therapeutics, Inc., 1,172,667 shares, as a passive investor on Jan 16, 2026. Filed Jan 23, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 1,172,667
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 5.50% | 1,172,667 |
| Millennium Management LLC | 5.50% | 1,172,667 |
| Millennium Group Management LLC | 5.50% | 1,172,667 |
| Israel A. Englander | 5.50% | 1,172,667 |
Source
Related
- Unicycive Therapeutics, Inc.
- Millennium Management LLC
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026